BETHLEHEM, Pa.--(BUSINESS WIRE)--June 27, 2006--OraSure Technologies, Inc. (NASDAQ:OSUR - News), the market leader in oral fluid diagnostics, today announced that it has entered into an approximate $6 million, multi-year purchase contract with the New York City Department of Mental Health and Hygiene to expand the use of OraQuick® ADVANCE(TM) Rapid HIV-1/2 Antibody Tests in the City.
